Viridian Therapeutics, Inc. VRDN Collaboration — Total revenues
Other product segments
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by Viridian Therapeutics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax.
The official record: Viridian Therapeutics, Inc.’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →
Ask your AI about Viridian Therapeutics, Inc.'s collaboration — total revenues.
Connect your AI assistant and compare segments, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Viridian Therapeutics, Inc.'s collaboration — total revenues?
- Viridian Therapeutics, Inc. (VRDN) reported collaboration — total revenues of $135K in Q1 2026.
- How has Viridian Therapeutics, Inc.'s collaboration — total revenues changed year-over-year?
- Viridian Therapeutics, Inc.'s collaboration — total revenues increased by 35.0% year-over-year, from $100K to $135K.
- What does collaboration — total revenues mean?
- This metric represents the total revenue generated specifically from collaborative arrangements, partnerships, or licensing agreements within the company's business segments. It captures income derived from shared research, development, or commercialization efforts with external entities. Monitoring this stream helps investors assess the company's ability to monetize its intellectual property and leverage strategic alliances to supplement core product development.